You'll also like these stocks for their track record of earnings growth.
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of customers.This data breach has led to concerns over the security of sensitive private information entrusted to ALECU. WHAT'S THIS ABOUT?
Drugmaker Abbott India reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.
NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of customers. This data breach has led to concerns over the security of sensitive private information entrusted to ALECU.
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Abbott Laboratories Employees Credit Union ("ALECU")recently disclosed a data breach that compromised the sensitive personal data of thousands of customers.This data breach has led to concerns over the security of sensitive private information entrusted to ALECU. WHAT'S THIS ABOUT?
'Mad Money' host Jim Cramer takes a closer look at the litigation facing Abbott Labs.
'Mad Money' host Jim Cramer takes a closer look at the litigation facing Abbott Labs.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of customers. This data breach has led to concerns over the security of sensitive private information entrusted to ALECU.
Shares of Abbott Laboratories (ABT) are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a jury cleared the two infant formula makers of liability for a boy's debilitating intestinal disease.
Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks.
A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC